Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers

Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain
Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers ( Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain )
8 Nov 2013

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013

Role of metronomics in cancer clinical trials and practice in developing countries

Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India
Role of metronomics in cancer clinical trials and practice in developing countries ( Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India )
19 Jul 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013

Next wave of successful drug therapy strategies in HER2-positive breast cancer

Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival

Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4  T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013

The future of PI3K/AKT/mTOR inhibitors in breast cancer

Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2  breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013